Search
Search Results
##search.searchResults.foundPlural##
-
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1508PDF: 529HTML: 266 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2675PDF: 761HTML: 213 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2829PDF: 963HTML: 3123flowcytometric result of peripheral blood sample: 173 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2440PDF: 783HTML: 1735 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2743PDF: 1114HTML: 3280 -
Pseudo-differentiation syndrome
1337PDF: 656HTML: 10845Figure 1: peripheral blood showing myeloblasts with auer rods: 117Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 102Figure 3: CXR showing pulmonary infiltartes with consolidation: 136Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 109Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 117 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2824PDF: 845HTML: 6518Untitled: 223Untitled: 185Untitled: 200Untitled: 207 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2765PDF: 1800HTML: 3663Pellagatti Fig 1: 210Pellagatti Fig. 2: 206 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1773PDF: 964HTML: 140 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
934PDF: 510HTML: 191 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1859PDF: 904HTML: 1765Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 158 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1594PDF: 801HTML: 159 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1175PDF: 749HTML: 1347Figure 1: 185Figure 2: 188 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
717PDF: 833PDF Supp. Files: 75HTML: 185 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1168PDF: 718Html: 93 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2002PDF: 757HTML: 3112 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3537PDF: 1475HTML: 4384CoverLetter: 183Figure1: 194 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1822PDF: 903HTML: 953Referring article: 748 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
942PDF: 1202HTML: 105







